Rhys Williams
@rhyswmpharm.bsky.social
MPharm. PGDip. FRPharmS.
Pharmacist.
All views are my own
Pharmacist.
All views are my own
It was a pleasure to speak at @cpcongress.bsky.social , discussing the benefits that #pharmacists can provide in the management of patients with #HeartFailure. #CPC25 #freedomfromfailure
May 9, 2025 at 4:29 PM
It was a pleasure to speak at @cpcongress.bsky.social , discussing the benefits that #pharmacists can provide in the management of patients with #HeartFailure. #CPC25 #freedomfromfailure
#MDT2025 has come to a close. It was great to see so many passionate delegates, the speakers were incredible and an infectious atmosphere for education, collaborating and networking. Diolch British Society for Heart Failure and Welsh Heart Failure Society 🇬🇧🫀🏴
May 2, 2025 at 5:53 PM
#MDT2025 has come to a close. It was great to see so many passionate delegates, the speakers were incredible and an infectious atmosphere for education, collaborating and networking. Diolch British Society for Heart Failure and Welsh Heart Failure Society 🇬🇧🫀🏴
Get your tickets now for the BSH’s MDT meeting taking place on Thursday 1-2 May at the Leonardo Hotel in Cardiff. Register at:
bshevents.eventsair.com/mdt-meeting-... #25in25 #freedomfromfailure #MDT2025
bshevents.eventsair.com/mdt-meeting-... #25in25 #freedomfromfailure #MDT2025
February 13, 2025 at 7:41 PM
Get your tickets now for the BSH’s MDT meeting taking place on Thursday 1-2 May at the Leonardo Hotel in Cardiff. Register at:
bshevents.eventsair.com/mdt-meeting-... #25in25 #freedomfromfailure #MDT2025
bshevents.eventsair.com/mdt-meeting-... #25in25 #freedomfromfailure #MDT2025
Join the BSH and the Welsh Heart Failure Society on the 1-2 May 2025, for their annual MDT at the Leonardo Hotel, Cardiff! Empowering Multidisciplinary Teams in Heart Failure Care'. Click here to register now: bshevents.eventsair.com/mdt-meeting-... #25in25 #freedomfromfailure #MDT2025
February 4, 2025 at 6:31 PM
Join the BSH and the Welsh Heart Failure Society on the 1-2 May 2025, for their annual MDT at the Leonardo Hotel, Cardiff! Empowering Multidisciplinary Teams in Heart Failure Care'. Click here to register now: bshevents.eventsair.com/mdt-meeting-... #25in25 #freedomfromfailure #MDT2025
Excited today to represent the British Society for Heart Failure, along with members of the board, at the #HouseofCommons to highlight the importance of #screening, #detection and management of #heartfailure in the UK #25in25 #findme #theFword
January 28, 2025 at 10:05 AM
Excited today to represent the British Society for Heart Failure, along with members of the board, at the #HouseofCommons to highlight the importance of #screening, #detection and management of #heartfailure in the UK #25in25 #findme #theFword
The British Society for Heart Failure MDT meeting is coming to Wales! Hope to see you all there! 🏴🫀🇬🇧
January 22, 2025 at 7:47 PM
The British Society for Heart Failure MDT meeting is coming to Wales! Hope to see you all there! 🏴🫀🇬🇧
If you can be anything in this world, be kind.
December 31, 2024 at 4:46 PM
If you can be anything in this world, be kind.
Merry Christmas to all my friends and colleagues. Wishing you all a happy and prosperous 2025! 🎄🎁🎅
December 25, 2024 at 4:46 PM
Merry Christmas to all my friends and colleagues. Wishing you all a happy and prosperous 2025! 🎄🎁🎅
December 12, 2024 at 11:07 PM
📖 ESC 2023 guidelines of CVD in Diabetes
Class I recommendation for SGLT2i and GLP1a in patients with diabetes and ASCVD or severe target organ damage
doi.org/10.1093/eurhea…
Class I recommendation for SGLT2i and GLP1a in patients with diabetes and ASCVD or severe target organ damage
doi.org/10.1093/eurhea…
December 3, 2024 at 10:58 PM
📖 ESC 2023 guidelines of CVD in Diabetes
Class I recommendation for SGLT2i and GLP1a in patients with diabetes and ASCVD or severe target organ damage
doi.org/10.1093/eurhea…
Class I recommendation for SGLT2i and GLP1a in patients with diabetes and ASCVD or severe target organ damage
doi.org/10.1093/eurhea…
“While patients with PAD experienced more adverse events, including amputations, the rates of these events were similar between dapagliflozin and placebo-treated patients with and without PAD”
Meta-analysis of DAPA-HF and DELIVER
doi.org/10.1093/eurhea…
Meta-analysis of DAPA-HF and DELIVER
doi.org/10.1093/eurhea…
December 3, 2024 at 10:58 PM
“While patients with PAD experienced more adverse events, including amputations, the rates of these events were similar between dapagliflozin and placebo-treated patients with and without PAD”
Meta-analysis of DAPA-HF and DELIVER
doi.org/10.1093/eurhea…
Meta-analysis of DAPA-HF and DELIVER
doi.org/10.1093/eurhea…
December 1st. Decorations up, feet up, home alone on the TV. It’s officially the jolly season! 🎄🎁⛄️
December 1, 2024 at 9:06 PM
December 1st. Decorations up, feet up, home alone on the TV. It’s officially the jolly season! 🎄🎁⛄️
Fantastic @BSHeartFailure #BSHAM2024 as always! The programme was truly diverse and did not disappoint. Next stop, MDT meeting, Cardiff, May 2025. See you there!! 👋 #CardioSky #PharmSky
November 23, 2024 at 7:57 AM
Fantastic @BSHeartFailure #BSHAM2024 as always! The programme was truly diverse and did not disappoint. Next stop, MDT meeting, Cardiff, May 2025. See you there!! 👋 #CardioSky #PharmSky
A very welcome surprise after a few difficult weeks. A HUGE thank you to those you nominated me and felt I was worthy of this honour. I am now in very good company indeed. #FRPharmS
November 16, 2024 at 12:53 PM
A very welcome surprise after a few difficult weeks. A HUGE thank you to those you nominated me and felt I was worthy of this honour. I am now in very good company indeed. #FRPharmS
Extended real-world treatment with the K+ binder #SZC was effective at main- taining normokalemia, and was associated with a greater uptake of #RAASi, a reduced rate of #HHF, and improvements in cardiac biomarkers in patients with #HFrEF.
link.springer.com/content/pdf/...
link.springer.com/content/pdf/...
November 14, 2024 at 7:43 PM
Extended real-world treatment with the K+ binder #SZC was effective at main- taining normokalemia, and was associated with a greater uptake of #RAASi, a reduced rate of #HHF, and improvements in cardiac biomarkers in patients with #HFrEF.
link.springer.com/content/pdf/...
link.springer.com/content/pdf/...